Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Total Current Liabilities (2020 - 2025)

Treace Medical Concepts' Total Current Liabilities history spans 6 years, with the latest figure at $30.6 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 12.28% year-over-year to $30.6 million; the TTM value through Dec 2025 reached $30.6 million, down 12.28%, while the annual FY2025 figure was $30.6 million, 12.28% down from the prior year.
  • Total Current Liabilities reached $30.6 million in Q4 2025 per TMCI's latest filing, down from $40.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $47.0 million in Q1 2024 to a low of $8.6 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $28.8 million, with a median of $30.4 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 110.58% in 2022, then decreased 29.48% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $18.2 million in 2021, then surged by 66.09% to $30.2 million in 2022, then skyrocketed by 48.89% to $45.0 million in 2023, then dropped by 22.45% to $34.9 million in 2024, then decreased by 12.28% to $30.6 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Total Current Liabilities are $30.6 million (Q4 2025), $40.9 million (Q3 2025), and $41.9 million (Q2 2025).